Approval · Notice of Compliance 14748 · 2013
ADEMPAS: Notice of Compliance 14748
Issued September 19, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14748
- Date
- September 19, 2013
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Soluble guanylate cyclase stimulator